Use search to browse all 100+ peptides
Bremelanotide, Vyleesi
A synthetic peptide analog of alpha-MSH used to treat hypoactive sexual desire disorder by activating melanocortin receptors to enhance sexual arousal.
Simon. James A JA; Kingsberg. Sheryl A SA; Portman. David D; Jordan. Robert R; Lucas. Johna J; Sadiq...
Bremelanotide (pt‑141) taken as a 1.75 mg injection before sex reliably lifts desire and cuts distress in pre‑menopausal women with low sexual drive, and it works the same way no matter the woman's age, weight, BMI, testosterone level, or whether she’s on hormonal birth control.
Spana. Carl C; Jordan. Robert R; Fischkoff. Steven S
In two small short‑term studies, giving obese women the peptide bremelanotide (also called pt‑141) under the skin three times a day for two weeks, or twice a day in a crossover design, cut their daily calorie intake by about 400 kcal and led to a modest weight loss of roughly 1–1.7 kg compared with placebo. The effect was seen quickly, within about two weeks, and the drug was generally tolerated, though some participants dropped out.
Lee. Jeong Hoo JH; Lee. Jenny E JE; Harsh. Veronica V; Clayton. Anita H AH
This review talks about medicines that can help women with low sexual desire, trouble getting aroused, or painful sex. It highlights that the peptide bremelanotide (pt‑141) works well for low desire, that new guidelines make testosterone use clearer, and that vaginal estrogen is safe for menopause‑related issues. It also notes that the way disorders are classified may affect treatment access, and that newer delivery methods could improve how these drugs work in the brain.
Kingsberg. Sheryl A SA; Clayton. Anita H AH; Portman. David D; Williams. Laura A LA; Krop. Julie J;...
Bremelanotide (pt‑141) taken as a 1.75 mg injection when needed boosted sexual desire and lowered distress about low desire in premenopausal women with hypoactive sexual desire disorder, with modest side effects like nausea, flushing, and headache.
Safarinejad. Mohammad Reza MR; Hosseini. Seyyed Yousof SY
A study gave men who didn't work with Viagra a nasal spray of bremelanotide (pt-141). About one‑third of the men saw improvement in erections, compared to less than 10% on placebo. The drug also boosted sexual satisfaction but caused more side effects.
Diamond. Lisa E LE; Earle. Dennis C DC; Heiman. Julia R JR; Rosen. Raymond C RC; Perelman. Michael A...
A single 20 mg intranasal dose of bremelanotide (PT‑141) gave pre‑menopausal women with sexual arousal disorder a noticeable boost in sexual desire and made them feel more satisfied with their arousal, even though the objective measure of vaginal blood flow didn't change.
Nappi. Rossella E RE; Tiranini. Lara L; Cucinella. Laura L; Martini. Ellis E; Bosoni. David D; Righi...
The paper reviews the few drugs that are actually approved for treating low sexual desire and other sexual problems in women. It highlights that the peptide bremelanotide (also called PT-141) works on demand and has solid evidence, alongside other options like flibanserin, testosterone patches, and vaginal hormones. The authors stress that you need good questionnaires and objective tests to pick the right people and track results.
Krupke. Hanna H; Zoratto. Nicole N; Rabut. Lucie L; Gao. Daniel D; Paunović. Nevena N; Klein C...
Scientists made a new, eco‑friendly suction patch you stick on the inside of your cheek that can deliver peptide drugs without a needle. It works for semaglutide (a weight‑loss/diabetes peptide) and bremelanotide (the active ingredient in PT‑141), giving decent blood levels after just a 10‑minute application, and the patch breaks down after use.
Clayton. Anita H AH; Althof. Stanley E SE; Kingsberg. Sheryl S; DeRogatis. Leonard R LR; Kroll. Robi...
A study in premenopausal women with sexual problems found that taking the peptide bremelanotide (BMT) under the skin, on an as‑needed basis, boosted the number of satisfying sexual events and improved overall sexual function scores. Doses of 1.25 mg or 1.75 mg worked better than placebo, with common side effects being mild nausea, flushing, and headache.
Mayer. Danielle D; Lynch. Sarah E SE
Bremelanotide (brand name Vyleesi) is a shot you can give yourself about 45 minutes before sex to boost desire. Clinical trials show it does raise sexual interest and cut distress, but the effect is modest. Common side effects are nausea, facial flushing, and headache. It’s safe with few drug interactions, but you can only take one dose per day and no more than eight doses a month, stopping after eight weeks if it doesn’t help.
Edinoff. Amber N AN; Sanders. Nicole M NM; Lewis. Kyle B KB; Apgar. Tucker L TL; Cornett. Elyse M EM...
Bremelanotide (also called PT-141) is a peptide that can boost sexual desire in women with low libido. A single 1.75 mg injection under the skin, given at least 45 minutes before sex, has been shown to improve desire, arousal, and orgasm compared to a placebo.
Nappi. Rossella E RE; Tiranini. Lara L; Martini. Ellis E; Bosoni. David D; Righi. Alessandra A; Cuci...
Female sexual problems are common and have many causes. Doctors first screen and give basic advice, then may use drugs or other methods. For women before menopause with low sexual desire, two pills are approved: flibanserin and the peptide bremelanotide (pt‑141). After menopause, testosterone patches and hormone therapy are the main options.
Clayton. Anita H AH; Lucas. Johna J; DeRogatis. Leonard R LR; Jordan. Robert R
A small Phase I trial showed that a single 20 mg nasal spray of bremelanotide (pt‑141) is safe and well tolerated in healthy men and women, even when taken with a moderate amount of alcohol. There were no serious side effects, no big changes in blood pressure, and the drug didn’t interact with alcohol in the body.
How. Andrew A; Jowdy. Christopher C; Novatcheva. Elli E; Clayton. Anita H AH
The review shows that the peptide bremelanotide (pt‑141) is an FDA‑approved, on‑demand injection that can boost sexual desire in women with low libido, working faster than daily pills like flibanserin. It also outlines safety tips and who might benefit most.
de Oliveira. Leonor L; Vignozzi. Linda L; Giraldi. Annamaria A; Varod. Shelly S; Corona. Giovanni G;...
The review says that low sexual desire in young women is complex, involving biology, mind, and social factors, and that the only approved drugs in the US are flibanserin and bremelanotide (pt‑141). It stresses that combining medication with therapy works best, but doctors still debate using drugs for younger women, and many women want more treatment options.
Ronghe. Vaishnavi V; Pannase. Krutika K; Gomase. Kavita P KP; Mahakalkar. Manjusha G MG
This review explains why some women have low sexual desire, covering hormones, brain chemistry, stress, relationships, and cultural factors. It describes how doctors diagnose the issue and lists treatment options, from therapy and lifestyle changes to drugs like hormone therapy, antidepressants, and newer agents such as bremelanotide (pt‑141). It also points out ongoing debates and research directions.
Kingsberg. Sheryl A SA; Clayton. Anita H AH; Pfaus. James G JG
This paper explains why many women have low sexual desire (HSDD) and why there are few approved drugs for it. It notes that the FDA recently approved flibanserin in the US, but other options like the peptide bremelanotide (PT‑141) are still experimental. The authors describe the brain chemicals involved and list several drugs being studied, including PT‑141, which targets the melanocortin system to boost desire.
Ila. Vishal V; Pozzi. Edoardo E; Gamage. Miyuru M; Ramasamy. Ranjith R
A recent review looks at using IV peptides (like PT‑141) and amino acids (arginine, citrulline) to treat erectile dysfunction. These compounds work differently from Viagra, targeting the brain or blood‑vessel health, and early studies suggest they might help, but big clinical trials are still missing. For DIY health enthusiasts, the info is interesting but not yet a proven, ready‑to‑use protocol.
Shadiack. Annette M AM; Sharma. Shubh D SD; Earle. Dennis C DC; Spana. Carl C; Hallam. Trevor J TJ
Bremelanotide (PT‑141) is a nasal peptide that activates brain melanocortin receptors and has been shown in Phase II trials to help men get erections and boost sexual desire in women, without the blood‑pressure drop seen with Viagra‑type drugs. It’s generally well tolerated, but the studies don’t give exact dosing or long‑term safety data for everyday use.
Sweeney. Patrick P; Gimenez. Luis E LE; Hernandez. Ciria C CC; Cone. Roger D RD
This review says the brain’s melanocortin system is a hot target for drugs that could help with weight issues, muscle loss, and even mood, and it points out that a few peptide drugs (like setmelanotide for obesity and bremelanotide/pt‑141 for low sexual desire) have already been approved, proving the safety of this drug class. For DIY biohackers, it means the science is solid, but there’s no new dosing recipe yet—just a heads‑up that future compounds may become available for metabolic and performance tweaks.